Wertpapierdatensatz · archiviertes Quartal
BHVN
Biohaven Ltd. · Healthcare · Biotechnology
16Erfasste Halter
-1Δ Inhaber
31.66MGehaltene Aktien
$446.69MGemeldeter Wert
+0Neue Positionen
−1Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -5.9% ·
Aktienfluss -0.6% ·
neue Nettopositionen -6.2%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +2 | 76.78M | $1.14B | +6 | −4 |
| Q1 2026 | 95 | 0 | 88.72M | $750.66M | +4 | −4 |
| Q4 2025 | 95 | -1 | 70.26M | $793.21M | +1 | −2 |
| Q3 2025 | 19 | +1 | 32.20M | $483.28M | +2 | −2 |
| Q2 2025 | 16 | -1 | 31.66M | $446.69M | — | −1 |
| Q1 2025 | 14 | -1 | 13.40M | $322.18M | — | −1 |
| Q4 2024 | 15 | +1 | 14.58M | $544.70M | +1 | — |
| Q3 2024 | 13 | 0 | 12.61M | $630.01M | — | — |
| Q2 2024 | 13 | — | 11.04M | $383.32M | — | — |
Wer es hält · Q2 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 9.25M | — | $130.51M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passiv) | 9.25M | — | $130.51M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 9.25M | — | $130.51M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 9.25M | — | $130.51M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passiv) | 9.25M | — | $130.51M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passiv) | 7.54M | — | $106.32M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passiv) | 3.54M | +3.4% | $49.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 3.17M | +12.3% | $44.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 3.17M | +12.3% | $44.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passiv) | 2.03M | +3.7% | $28.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passiv) | 2.03M | +3.7% | $28.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.66M | — | $23.49M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.66M | — | $23.49M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.66M | — | $23.49M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Millennium Management ✦ | 1.63M | +80.6% | $22.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Norges Bank ✦ (passiv) | 902.57K | 0.0% | $12.74M | 0.0% | Held | 5 | SEC ↗ |
| 31 | Adage Capital Partners ✦ | 630.03K | +14.3% | $8.89M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 518.78K | +1401.0% | $7.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 518.78K | +1401.0% | $7.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 323.35K | -73.7% | $4.56M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 323.35K | -73.7% | $4.56M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Capital World Investors ✦ | 250.00K | 0.0% | $3.53M | 0.0% | Held | 5 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 77.85K | -32.2% | $1.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 77.85K | -32.2% | $1.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 77.85K | -32.2% | $1.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 77.85K | -32.2% | $1.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 73.63K | +6.5% | $1.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Wellington Management ✦ | 37.46K | -95.3% | $528,547 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 37.46K | -95.3% | $528,547 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 37.46K | -95.3% | $528,547 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 37.46K | -95.3% | $528,547 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 46 | Marshall Wace ✦ | 26.38K | -88.7% | $372,208 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | Marshall Wace ✦ | 26.38K | -88.7% | $372,208 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Renaissance Technologies | $2.62M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 51.20K Anteile, $433 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q2 2025 ·
Methodik ·
Über die API abrufen